Differential distribution of 5HT(1D)- and 5HT(1B)-immunoreactivity within the human trigemino-cerebrovascular system: Implications for the discovery of new antimigraine drugs

Cephalalgia

Volumn 17, Issue 8, 1997, Pages 833-842

  Longmore, J ^a   Shaw, D ^a   Smith, D ^a   Hopkins, R ^a   McAllister, G ^a   Pickard, J D ^b   Sirinathsinghji, D J S ^a   Butler, A J ^a   Hill, R G ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

5HT(1B 1D) receptor subtypes; Antimigraine drugs; Receptor localization; Trigeminal neurones

Indexed keywords

ANTIMIGRAINE AGENT; POLYCLONAL ANTIBODY; RECEPTOR SUBTYPE; SEROTONIN 1 AGONIST; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR; SUMATRIPTAN; SYNTHETIC PEPTIDE; SEROTONIN;

ADULT; AGED; ARTICLE; BRAIN BLOOD VESSEL; DRUG MECHANISM; FEMALE; HEADACHE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MIGRAINE; PROTEIN LOCALIZATION; TRIGEMINAL NERVE; VASOCONSTRICTION; AMINO ACID SEQUENCE; BRAIN CIRCULATION; BRAIN STEM; CHEMISTRY; CLINICAL TRIAL; CYTOLOGY; DURA MATER; MIDDLE AGED; MOLECULAR GENETICS; PHYSIOLOGY; SENSORY NERVE CELL; VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; BRAIN STEM; CEREBROVASCULAR CIRCULATION; DURA MATER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MIGRAINE DISORDERS; MOLECULAR SEQUENCE DATA; NEURONS, AFFERENT; SEROTONIN; TRIGEMINAL NERVE;

EID: 0031283073     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.1997.1708833.x     Document Type: Article

References (34)

1. Jansen I, Uddman R, Ekman R, Olesen J, Ottoson A, Edvinssion L. Distribution and effects of neuropeptide Y, vasoactive intestinal peptide, substance P and calcitonin generelated peptide in human middle meningeal arteries: comparison with cerebral and temporal arteries. Peptides 1992; 13:527-36
2. Feindel W, Penfield W, McNaughton F. The tentorial nerves and localisation of intracranial pain in man. Neurology 1969;10:555-63
3. Ray BS, Wolff HG. Experimental studies on headache. Pain sensitive structures of the head and their significance in headache. Arch Surg 1940;41:813-56
4. Martins IP, Baeta E, Paiva T, Campo T, Gomes L. Headaches during intracranial endovascular procedures: a possible model of vascular headache. Headache 1993;33:227-33
5. Uddman R, Edvinsson L, Ekman R, Kingman T, McCulloch J. Innervation of the feline cerebral vasculature by nerve fibres containing calcitonin gene-related peptide: trigeminal origin and co-existence with substance P. Neurosci Lett 1985;62: 131-6
6. Mayberg MR, Zervas NT, Moskowitz MA. Trigeminal projections to supratentorial pial and durai blood vessels in cats demonstrated by horseradish peroxidase histochemistry. J Comp Neurol 1984;223:46-56
7. Saito K, Greenberg S, Moskowitz MA. Trigeminal origin of β-preprotachykinin products in feline pial blood vessels. Neurosci Lett 1987;76:69-73
8. Arrab MAR, Delgado T, Wiklund L, Svengaard NA. Brain stem terminations of the trigeminal and upper spinal innervation of the cerebrovascular system. J Cerebrovasc Blood Flow Metab 1988;8:54-63
9. Salt TE, Hill RG. Neurotransmitter candidates of somatosensory primary afferent fibres. Neuroscience 1983;10: 1083-103
10. Humphrey PPA, Feniuk W. Mode of action of the antimigraine drug sumatriptan. Trends Pharmacol Sci 1991; 12:444-6
11. Moskowitz MA. Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol Sci 1992;13:307-12
12. 1 antagonist CP-99,994 on plasma protein extravasation in dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats. Neuropharmacology 1995;34:255-61
13. Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 1990;28:183-7
14. 1D, receptor genes. Trends Pharmacol Sci 1992;13:152-9
15. 1D, receptor subtypes. Trends Pharmacol Sci 1996;17:103-5
16. 1Db receptor subtype in human and bovine cerebral arteries. Mol Pharmacol 1993;44:242-6
17. Ullmer C, Schmuck K, Kalkman, Lubbert H. Expression of serotonin receptor mRNAs in blood vessels. FEBS Lett 1995; 370:215-21
18. Kaumann AJ, Parsons AA, Brown AA. Human arterial constrictor serotonin receptors. Cardiovasc Res 1993;27: 2094-103
19. 1B serotonin receptor gene expression in trigeminal ganglia: implications for antimigraine drug development. Proc Natl Acad Sci USA 1994;94:3666-9
20. Bouchelet I, Cohen Z, Case B, Sequela P, Hamel E. Differential expression of sumatriptan-sensitive 5-hydroxytryptamine receptors in human trigeminal ganglia and cerebral blood vessels. Mol Pharmacol 1996;50:219-23
21. Shi SR, Key ME, Kalra KL. Antigen retrieval in formalin fixed paraffin embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991;39: 741-8
22. 1B-receptor subtype specific antibodies. J Neurosci Methods 1997 (in press)
23. 1B receptors. Mol Pharmacol 1996;49:761-5
24. Carpenter MB, Sutin J. The autonomie nervous system. In: Human neuroanatomy. Baltimore: Waverlv Press, 1984: 209-31
25. 1Dα-receptors. Naunyn Schmiedebergs Arch Pharmacol 1996;353:272-80
26. Torvik A. Afferent connections to the sensory trigeminal nuclei, the nucleus of the solitary tract and adjacent structures: an experimental study in the rat. J Comp Neurol 1956;106: 51-142
27. 3H]sumatriptan binding in cat brain stem and spinal cord. Eur J Pharmacol 1995;280:175-8
28. Goadsby PJ, Knight YE. Direct evidence for central sites of action of zolmitriptan (311C90): an autographic study in cat. Cephalalgia 1997;17:153-8
29. 1F receptor binding sites in the guinea-pig brain: an autoradiographic study. Naunyn Schmiedebergs Arch Pharmacol 1995;352:263-75
30. 1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets. Neuropharmacology 1996;35: 1121-9
31. Coadsby PJ. Central and peripheral 5-hydroxytryptamine receptor effects: what have we learnt? In: Sandler M, Ferrari MD, Harnett S, editors. Migraine: pharmacology and genetics. London: Chapman & Hall, 1946:67-86
32. Mantyh PW, DeMaster E, Malhorta A, Ghilardi JR, Rogers SD, Mantyh CR, et al. Receptor endocytosis and dendrite reshaping in spinal neurones after somatosensory stimulation. Science 1995;268:1624-32
33. Ferrari MD, Gijsma H, Block GA, Kramer MS, Matzura-Wolfe D, Teal JD, et al. Double-blind, placebo-controlled, dose-finding study of rizatriptan (MK-0462) in acute migraine. American Association of the Study of Headache, San Diego, CA, 31st May to 2nd June 1996
34. Cumberbatch MJ, Hill RG, Hargreaves RJ. Rizatriptan has central antinociceptive effects against durally evoked responses. Eur J Pharmacol 1997;328:37-40